Show simple item record

dc.contributor.authorMalca-Tocas, M.M.
dc.contributor.authorUgarte-Gil, C.
dc.contributor.authorMatos-Miranda, C.P.
dc.contributor.authorBecerra-Chauca, N.
dc.contributor.authorCeballos-Pacheco, C.
dc.contributor.authorBroncano-Huasasquiche, O.
dc.contributor.authorFernández-Butrón, A.C.
dc.contributor.authorLivano-Yberico, T.
dc.contributor.authorVargas-Caycho, Y.
dc.contributor.authorHuaringa-Marcelo, J.
dc.contributor.authorSalvador-Salvador, S.
dc.contributor.authorTimaná-Ruiz, R.
dc.contributor.authorCarrera-Acosta, L.
dc.date.accessioned2025-10-31T18:39:30Z
dc.date.available2025-10-31T18:39:30Z
dc.date.issued2021
dc.identifier.urihttps://hdl.handle.net/20.500.12805/5732
dc.description.abstractBackground: This article summarizes the clinical practice guideline (CPG) for the management of early-stage cervical cancer (IA1, IA2, IB1, IB2 o IIA1) in the Social Security of Peru (EsSalud). Objective: To provide clinical recommendations based on evidence for the management of early-stage cervical cancer in EsSalud. Material and methods: A CPG for the management of early-stage cervical cancer in EsSalud was developed. To this end, a guideline development group (local GDG) was established, including medical specialists and methodologists. The local GDG formulated 8 clinical questions to be answered by this CPG. Systematic searches of systematic reviews and -when it was considered pertinent-primary studies were conducted in Pubmed, Embase y CENTRAL during 2017 - 2018. The evidence to answer each of the posed clinical questions was selected. The quality of the evidence was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology. In periodic work meetings, the local GDG used the GRADE methodology to review the evidence and formulate the recommendations, points of good clinical practice, and the flowchart of management. Finally, the CPG was approved with Resolution No. N° 27-IETSI-ESSALUD-2020. Results: This CPG addressed 8 clinical questions on the management of early-stage cervical cancer (IA1, IA2, IB1, IB2 o IIA1). Based on these questions, 10 recommendations (2 strong recommendations and 8 weak recommendations), 7 points of good clinical practice, and 4 flowcharts were formulated. Conclusion: This article summarizes the methodology and evidence-based conclusions from the CPG for the management of early-stage cervical cancer in EsSalud.en_US
dc.formatapplication/pdf
dc.language.isospa
dc.publisherMedical Body of the Almanzor Aguinaga Asenjo National Hospital
dc.relation.ispartofurn:issn:2227-4731
dc.rightshttps://purl.org/coar/access_right/c_abf2
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectSDG 3en_US
dc.subjectCervical Cancer Prevention and HPV Awarenessen_US
dc.subjectCervical Cancer Treatment and Prognostic Factorsen_US
dc.titleGuía de práctica clínica para el manejo quirúrgico de la obesidad en adultos en el Seguro Social del Perú (EsSalud)es_PE
dc.typehttps://purl.org/coar/resource_type/c_2df8fbb1
dc.identifier.doihttps://doi.org/10.35434/rcmhnaaa.2021.144.1462
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.02.11
dc.type.otherResearch article
dc.identifier.journalRevista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo
dc.type.versionhttps://purl.org/coar/version/c_970fb48d4fbd8a85


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

https://purl.org/coar/access_right/c_abf2
Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2